Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative breast cancer: does it help tailor adjuvant treatment?
Details
Publication Year 2024-05-01,Volume 35,Issue #5,Page 409-411
Journal Title
Annals of Oncology
Publication Type
Editorial
Publisher
Elsevier
Department(s)
Laboratory Research
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-04-22 03:31:59
Last Modified: 2025-04-22 03:32:08

© 2025 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙